Status:
UNKNOWN
IL37,Tlymphocytes,NK Cells in Pathogenesis of ITP
Lead Sponsor:
Assiut University
Conditions:
ITP
Eligibility:
All Genders
2-60 years
Brief Summary
To evaluate the role of IL37 in pathogenesis of ITP and to study the relation between IL37,Tlymphocytes,NK cells in ITP
Detailed Description
Idiopathic thrombocytopenia or immune thrombocytopenia (ITP) is a hematological condition which is characterized by a low platelet count of less than 100 x 109L . Symptoms of ITP can vary but tend to ...
Eligibility Criteria
Inclusion
- Patients with ITP (moderate and sever) different age group.
Exclusion
- Patients with stroke and myocardial infarction,malignant tumors or pregnancy.
Key Trial Info
Start Date :
July 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04482777
Start Date
July 30 2023
End Date
September 1 2023
Last Update
August 9 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.